Education
About Us
Working with TipRanks
Follow Us
Kestra Medical Technologies Ltd. (KMTS)
NASDAQ:KMTS
RESEARCH TOOLSreports
Total Valuation
Kestra Medical Technologies Ltd. has a market cap or net worth of $951.75M. The enterprise value is $1.04B.
Market Cap$951.75M
Enterprise Value$1.04B
Share Statistics
Kestra Medical Technologies Ltd. has 51,348,656 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding51,348,656
Owned by Insiders1.16%
Owned by Institutions68.86%
Financial Efficiency
Kestra Medical Technologies Ltd.’s return on equity (ROE) is -0.55 and return on invested capital (ROIC) is -41.26%.
Return on Equity (ROE)-0.55
Return on Assets (ROA)-0.38
Return on Invested Capital (ROIC)-41.26%
Return on Capital Employed (ROCE)-0.41
Revenue Per Employee199.38K
Profits Per Employee-379.38K
Employee Count300
Asset Turnover0.20
Inventory Turnover5.42
Valuation Ratios
The current PE Ratio of Kestra Medical Technologies Ltd. is ―. Kestra Medical Technologies Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value5.80
Price to FCF―
Price to Operating Cash Flow-13.80
PEG Ratio―
Income Statement
In the last 12 months, Kestra Medical Technologies Ltd. had revenue of 59.81M and earned -113.81M in profits. Earnings per share was -5.13.
Revenue59.81M
Gross Profit24.21M
Operating Income-106.38M
Pretax Income-113.68M
Net Income-113.81M
EBITDA-97.98M
Earnings Per Share (EPS)-5.13
Cash Flow
In the last 12 months, operating cash flow was -42.08M and capital expenditures -12.11M, giving a free cash flow of -54.19M billion.
Operating Cash Flow-42.08M
Free Cash Flow-54.19M
Free Cash Flow per Share-1.06
Dividends & Yields
Kestra Medical Technologies Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.81
52-Week Price Change-15.63%
50-Day Moving Average16.21
200-Day Moving Average―
Relative Strength Index (RSI)57.09
Average Volume (3m)303.93K
Important Dates
Kestra Medical Technologies Ltd. upcoming earnings date is Sep 11, 2025, After Close (Confirmed).
Last Earnings DateJul 15, 2025
Next Earnings DateSep 11, 2025
Ex-Dividend Date―
Financial Position
Kestra Medical Technologies Ltd. as a current ratio of 6.72, with Debt / Equity ratio of 21.57%
Current Ratio6.72
Quick Ratio6.55
Debt to Market Cap0.03
Net Debt to EBITDA1.97
Interest Coverage Ratio-13.75
Taxes
In the past 12 months, Kestra Medical Technologies Ltd. has paid 135.00K in taxes.
Income Tax135.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Kestra Medical Technologies Ltd. EV to EBITDA ratio is -10.19, with an EV/FCF ratio of -9.87.
EV to Sales16.69
EV to EBITDA-10.19
EV to Free Cash Flow-9.87
EV to Operating Cash Flow-12.87
Balance Sheet
Kestra Medical Technologies Ltd. has $237.59M in cash and marketable securities with $44.31M in debt, giving a net cash position of -$193.28M billion.
Cash & Marketable Securities$237.59M
Total Debt$44.31M
Net Cash-$193.28M
Net Cash Per Share-$3.76
Tangible Book Value Per Share$4.15
Margins
Gross margin is 36.76%, with operating margin of -177.85%, and net profit margin of -190.28%.
Gross Margin36.76%
Operating Margin-177.85%
Pretax Margin-190.05%
Net Profit Margin-190.28%
EBITDA Margin-163.80%
EBIT Margin-177.12%
Analyst Forecast
The average price target for Kestra Medical Technologies Ltd. is $24.58, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$24.58
Price Target Upside36.56% Upside
Analyst ConsensusModerate Buy
Analyst Count6
Revenue Growth Forecast115.05%
EPS Growth Forecast-21.37%